Literature DB >> 15659820

Expression of the insulin-like growth factor-I receptor and proapoptotic Bax and Bak proteins in human colorectal cancer.

Mariusz Koda1, Joanna Reszec, Mariola Sulkowska, Luiza Kanczuga-Koda, Stanislaw Sulkowski.   

Abstract

Insulin-like growth factor-I (IGF-I) and IGF-I receptor (IGF-IR), despite their well-known roles in cell survival and proliferation, can also weakly enhance apoptosis. To study the relationships between the IGF-IR and Bax as well as Bak, 144 cases of colorectal cancer were examined by immunohistochemistry, using the avidin-biotin-peroxidase method. The results were correlated with selected clinicopathological features of colorectal cancer and with the expression of IGF-IR, Bax, and Bak in normal colon mucosa. In Bax-, Bak-, or IGF-IR-positive cancers, the adjacent colorectal mucosa revealed positive immunostaining for these proteins. In the majority of Bax-, Bak-, or IGF-IR-negative tumors, we observed no staining for these proteins in adjacent mucosa. The strong immunostaining for IGF-IR, Bax, and Bak was noted in 50.8, 55.5, and 49.3% of tumors, respectively. We observed positive correlations between IGF-IR and Bax (P < 0.002, r = 0.302), between IGF-IR and Bak (P < 0.0001, r = 0.407), and between Bax and Bak (P < 0.0001, r = 0.474). No relationship was noted between IGF-IR expression and tumor grade, stage, or lymph node status. We found negative associations between Bax, Bak, and tumor grade (P < 0.01 and P < 0.003, respectively), but no relationships between Bax and Bak and tumor stage or between Bax and Bak and lymph node status. Our results demonstrate that, in addition to overexpressed IGF-IR, there are relationships between IGF-IR and proapoptotic proteins in colorectal carcinomas that could contribute to increased cell turnover and the progression of colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15659820     DOI: 10.1196/annals.1329.047

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  12 in total

1.  Changes in electric charge and phospholipids composition in human colorectal cancer cells.

Authors:  Izabela Dobrzyńska; Barbara Szachowicz-Petelska; Stanisław Sulkowski; Zbigniew Figaszewski
Journal:  Mol Cell Biochem       Date:  2005-08       Impact factor: 3.396

2.  Membrane rafts segregate pro- from anti-apoptotic insulin-like growth factor-I receptor signaling in colon carcinoma cells stimulated by members of the tumor necrosis factor superfamily.

Authors:  Maryse Remacle-Bonnet; Françoise Garrouste; Gilbert Baillat; Frédéric Andre; Jacques Marvaldi; Gilbert Pommier
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

Review 3.  The biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized care.

Authors:  Marina De Rosa; Daniela Rega; Valeria Costabile; Francesca Duraturo; Antonello Niglio; Paola Izzo; Ugo Pace; Paolo Delrio
Journal:  Therap Adv Gastroenterol       Date:  2016-08-07       Impact factor: 4.409

4.  Dietary Insulin Load and Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 (Alliance).

Authors:  Vicente Morales-Oyarvide; Chen Yuan; Ana Babic; Sui Zhang; Donna Niedzwiecki; Jennie C Brand-Miller; Laura Sampson-Kent; Xing Ye; Yanping Li; Leonard B Saltz; Robert J Mayer; Rex B Mowat; Renaud Whittom; Alexander Hantel; Al Benson; Daniel Atienza; Michael Messino; Hedy Kindler; Alan Venook; Shuji Ogino; Kana Wu; Walter C Willett; Edward L Giovannucci; Brian M Wolpin; Jeffrey A Meyerhardt; Charles S Fuchs; Kimmie Ng
Journal:  J Natl Cancer Inst       Date:  2019-02-01       Impact factor: 13.506

Review 5.  Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer.

Authors:  Hui-Yan Luo; Rui-Hua Xu
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

6.  Prognostic implications of BAX protein expression and microsatellite instability in all non-metastatic stages of primary colon cancer treated by surgery alone.

Authors:  Oliver Nehls; Holger G Hass; Thomas Okech; Silke Zenner; Chih-Jen Hsieh; Mario Sarbia; Franz Borchard; Hans-Helmut Gruenagel; Vera Gaco; Rainer Porschen; Michael Gregor; Bodo Klump
Journal:  Int J Colorectal Dis       Date:  2009-02-17       Impact factor: 2.571

Review 7.  Review of the molecular profile and modern prognostic markers for gastric lymphoma: how do they affect clinical practice?

Authors:  Leonidas Alevizos; Ilias P Gomatos; Spyridon Smparounis; Manousos M Konstadoulakis; Georgios Zografos
Journal:  Can J Surg       Date:  2012-04       Impact factor: 2.089

Review 8.  Chemoresistance in gliomas.

Authors:  Chen Lu; Amal Shervington
Journal:  Mol Cell Biochem       Date:  2008-02-08       Impact factor: 3.396

Review 9.  A review of tumor-specific fluorescence-guided surgery for colorectal cancer.

Authors:  Hannah M Hollandsworth; Michael A Turner; Robert M Hoffman; Michael Bouvet
Journal:  Surg Oncol       Date:  2020-11-29       Impact factor: 3.279

10.  Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients.

Authors:  F Cappuzzo; M Varella-Garcia; G Finocchiaro; M Skokan; S Gajapathy; C Carnaghi; L Rimassa; E Rossi; C Ligorio; L Di Tommaso; A J Holmes; L Toschi; G Tallini; A Destro; M Roncalli; A Santoro; P A Jänne
Journal:  Br J Cancer       Date:  2008-06-24       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.